About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Eribulin in mTNBC Patients | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT04541420

Eribulin in mTNBC Patients

To evaluate the efficacy and safety of Eribulin in patients with advanced breast cancer.

Lead sponsor: Fudan University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Fudan University

Age

All ages

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•1. Advanced breast cancer included unresectable locally advanced breast cancer, de novo stage IV breast cancer, and recurrent metastatic breast cancer.
•2. Eribulin treatment of advanced breast cancer for at least one cycle, between Dec 2019 and Aug 2020.
•3. Available medical history.

Exclusion Criteria

•1\. Incomplete medical history.

Related studies

RECRUITINGPhase 1

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

NCT06347068 · Breast Cancer, Relapse, and more

RECRUITINGPhase 3

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

NCT06500481 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more

A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship

NCT07655934 · Breast Cancer

RECRUITINGPhase 1/2

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

NCT07288359 · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, and more

Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

NCT07436078 · Female Breast Cancer, Prostate Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 3, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment208

Start dateDec 2019

Last updatedFeb 3, 2021

Condition

Locations shown

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 3, 2021Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions